Rusiana, Florencia M.
HRN: 05-93-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2026
CEFTRIAXONE 1G (VIAL)
04/02/2026
04/09/2026
IV
2 Grams
OD
Cystic Mass, Right Scapula
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: